文献速递精神分裂症与精神病性障碍

维生素D与精神分裂症:二十年研究回顾

Vitamin D and schizophrenia: 20 years on.
PubMed 文献 · Mol Psychiatry · 2021-01-26

本文综述了维生素D缺乏与精神分裂症关联的流行病学研究、动物模型及补充试验。系统综述与荟萃分析基本证实患者维生素D缺乏风险增加并扩展至首发精神病,但因果解释需谨慎;早期生命维生素D缺乏增加精神分裂症风险的假说仍合理,值得继续研究。

要点

  • 精神分裂症患者维生素D缺乏风险高于健康对照,并扩展至首发精神病。
  • 动物模型显示发育期维生素D缺乏改变脑发育,多巴胺系统改变常被报道。
  • 现有维生素D补充试验结果不一致,因果解释需谨慎。

核心结论

  • 维生素D缺乏与精神分裂症的关联在系统综述与荟萃分析中得到基本证实,并扩展至首发精神病。
  • 早期生命维生素D缺乏可能增加精神分裂症风险的假说仍合理,值得继续研究。

研究设计与样本

  • 本文为系统综述与荟萃分析,纳入观察性研究并汇总动物模型与补充试验证据。

主要发现

  • 两项突出研究报告新生儿维生素D缺乏与精神分裂症风险增加相关。
  • 发育期维生素D缺乏动物模型描述脑发育改变,导致一系列与精神分裂症相关的神经生物学和行为表型。
  • 发育期维生素D缺乏模型中多巴胺系统改变常被报道,谷氨酸和γ-氨基丁酸(GABA)系统研究较少。
  • 精神分裂症患者维生素D缺乏风险高于健康对照,系统综述与荟萃分析基本证实该关联并扩展至首发精神病。
  • 成人维生素D缺乏动物模型产生细微神经化学改变和认知影响,但未出现与精神分裂症相关的行为表型。

临床怎么用

  • 临床应关注精神分裂症及首发精神病患者的维生素D缺乏风险。
  • 对关联的因果解释需谨慎,因患者一般健康、饮食、活动及其他医疗状况均影响维生素D水平。
  • 现有维生素D补充试验结果不一致,临床决策应结合个体情况。

局限性

  • 现有维生素D补充试验结果不一致。
  • 患者一般健康较差、饮食较差、活动较少及合并其他医疗状况等因素降低维生素D水平,限制因果推断。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Many epidemiological studies have highlighted the link between vitamin D deficiency and schizophrenia. In particular, two prominent studies report an association between neonatal vitamin D deficiency and an increased risk of schizophrenia. In parallel, much has been learnt about the role of vitamin D in the developing central nervous system over the last two decades. Studies in rodent models of developmental vitamin D (DVD)-deficiency describe how brain development is altered leading to a range of neurobiological and behavioral phenotypes of interest to schizophrenia. While glutamate and gamma aminobutyric acid (GABA) systems have been little investigated in these models, alterations in developing dopamine systems are frequently reported. There have been far more studies reporting patients with schizophrenia have an increased risk of vitamin D deficiency compared to well controls. Here we have conducted a systematic review and meta-analysis that basically confirms this association and extends this to first-episode psychosis. However, patients with schizophrenia also have poorer general health, poorer diets, are frequently less active and also have an increased risk of other medical conditions, all factors which reduce circulating vitamin D levels. Therefore, we would urge caution in any causal interpretation of this association. We also summarize the inconsistent results from existing vitamin D supplementation trials in patients with schizophrenia. In respect to animal models of adult vitamin D deficiency, such exposures produce subtle neurochemical alterations and effects on cognition but do not appear to produce behavioral phenotypes of relevance to schizophrenia. We conclude, the hypothesis that vitamin D deficiency during early life may increase the risk of schizophrenia remains plausible and warrants ongoing research.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Cui X, McGrath JJ, Burne THJ, et al. Vitamin D and schizophrenia: 20 years on. Mol Psychiatry. 2021. PMID: 33500553. doi:10.1038/s41380-021-01025-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。